How many milligrams of potassium citrate are in a 10 mEq tablet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Potassium Citrate Dosing Conversion

A 10 mEq tablet of potassium citrate contains 1080 mg of potassium citrate. 1

Dosing Information

The FDA-approved potassium citrate formulations are available in three standardized strengths 1:

  • 5 mEq tablet = 540 mg potassium citrate
  • 10 mEq tablet = 1080 mg potassium citrate
  • 15 mEq tablet = 1620 mg potassium citrate

Clinical Context

This standardized dosing is important for several reasons:

Therapeutic Range: Typical dosing for kidney stone prevention ranges from 30-80 mEq/day divided into 3-4 doses 1. A common regimen is 10 mEq three times daily (30 mEq total), which translates to 3240 mg of potassium citrate per day.

Potassium Content: Each 10 mEq tablet delivers approximately 10 mEq of elemental potassium to the body, which is clinically relevant when monitoring for hyperkalemia risk, particularly in patients with renal insufficiency or those taking medications that affect potassium handling 1.

Safety Monitoring: The potassium load from these tablets requires consideration in patients at risk for hyperkalemia. Severe hyperkalemia (>6.5 mmol/L) can cause life-threatening cardiac arrhythmias 2. Regular monitoring of serum potassium and ECG changes is essential during therapy 1.

Important Caveats

  • Tablets must be swallowed whole without crushing, chewing, or sucking to prevent gastrointestinal irritation 1
  • The wax-matrix formulation provides controlled release over approximately 12 hours 1
  • Patients with renal insufficiency may require dose adjustment or may be contraindicated from use 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.